Log In
Print
BCIQ
Print
Print this Print this
 

TAS-2985

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionIrreversible fibroblast growth factor (FGF) receptor (FGFR) inhibitor
Molecular Target Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today